Increased intracellular GSH levels and overexpression of GSH-metabolizing enzymes, such as glutathione transferase pi-1 (GSTP-1), have been correlated with drug resistance and reported in TMZ-resistant GBM cells [16,17]. This evidence concerns the gene GSTP1 and glioblastoma.